{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:18:27Z","timestamp":1790979507613,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T00:00:00Z","timestamp":1374278400000},"content-version":"vor","delay-in-days":1176,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.acvd.2010.04.008","type":"journal-article","created":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T04:54:07Z","timestamp":1277960047000},"page":"317-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome"],"prefix":"10.1016","volume":"103","author":[{"given":"Delphine","family":"Detaint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Aegerter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tubach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Plauchu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Dulac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence Olivier","family":"Faivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Ange","family":"Delrue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Collignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Odent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tchitchinadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bouffard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Arnoult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Jondeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2010.04.008_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ajmg.1320290316","article-title":"International nosology of heritable disorders of connective tissue, Berlin, 1986","volume":"29","author":"Beighton","year":"1988","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.acvd.2010.04.008_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R","article-title":"Revised diagnostic criteria for the Marfan syndrome","volume":"62","author":"De Paepe","year":"1996","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.acvd.2010.04.008_bib3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJMoa055695","article-title":"Aneurysm syndromes caused by mutations in the TGF-beta receptor","volume":"355","author":"Loeys","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2010.04.008_bib4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/520125","article-title":"Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study","volume":"81","author":"Faivre","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.acvd.2010.04.008_bib5","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1161\/CIRCULATIONAHA.109.887042","article-title":"Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders","volume":"120","author":"Attias","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2010.04.008_bib6","first-page":"46","article-title":"Autosomal dominant Marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes","volume":"53","author":"Boileau","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.acvd.2010.04.008_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.hco.0000162398.21972.cd","article-title":"Molecular genetics of Marfan syndrome","volume":"20","author":"Boileau","year":"2005","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.acvd.2010.04.008_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1511","article-title":"A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2","volume":"37","author":"Loeys","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.acvd.2010.04.008_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM200003093421001","article-title":"Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type","volume":"342","author":"Pepin","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2010.04.008_bib10","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/01.CIR.103.20.2469","article-title":"Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder","volume":"103","author":"Vaughan","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2010.04.008_bib11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJM199904293401702","article-title":"Replacement of the aortic root in patients with Marfan's syndrome","volume":"340","author":"Gott","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2010.04.008_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/hrt.75.4.389","article-title":"Aortic root complications in Marfan's syndrome: identification of a lower risk group","volume":"75","author":"Legget","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2010.04.008_bib13","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1161\/CIRCULATIONAHA.107.693523","article-title":"Medical management of Marfan syndrome","volume":"117","author":"Keane","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2010.04.008_bib14","first-page":"123","article-title":"A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment","volume":"129","author":"Halpern","year":"1971","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/j.acvd.2010.04.008_bib15","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome","volume":"330","author":"Shores","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2010.04.008_bib16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.amjcard.2006.08.048","article-title":"Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome","volume":"99","author":"Ladouceur","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2010.04.008_bib17","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0002-9149(99)00101-0","article-title":"Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome","volume":"83","author":"Rossi-Foulkes","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2010.04.008_bib18","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/01.CIR.99.20.2677","article-title":"Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome","volume":"99","author":"Jondeau","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2010.04.008_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9149(98)00315-4","article-title":"Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome","volume":"82","author":"Groenink","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2010.04.008_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0002-9149(94)90405-7","article-title":"Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome","volume":"74","author":"Jeremy","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2010.04.008_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1022860919684","article-title":"Magnetic resonance imaging of the main pulmonary artery: reliable assessment of dimensions in Marfan patients on a simple axial spin echo image","volume":"19","author":"Nollen","year":"2003","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2010.04.008_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0002-8703(97)70248-5","article-title":"Heterogeneous aortic response to acute beta-adrenergic blockade in Marfan syndrome","volume":"133","author":"Haouzi","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2010.04.008_bib23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-8703(99)70362-5","article-title":"Effect of long-term beta-blockade on aortic root compliance in patients with Marfan syndrome","volume":"137","author":"Rios","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2010.04.008_bib24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/01.CIR.79.4.854","article-title":"Arterial hemodynamic indexes in Marfan's syndrome","volume":"79","author":"Yin","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2010.04.008_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.humpath.2008.08.002","article-title":"Tissue diffusion and retention of metalloproteinases in ascending aortic aneurysms and dissections","volume":"40","author":"Borges","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.acvd.2010.04.008_bib26","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.CIR.0000027905.26586.E8","article-title":"Clinical and pathophysiological implications of a bicuspid aortic valve","volume":"106","author":"Fedak","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2010.04.008_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.2516","article-title":"Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway","volume":"218","author":"Gomez","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.acvd.2010.04.008_bib28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCRESAHA.107.157776","article-title":"Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome","volume":"101","author":"Chung","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2010.04.008_bib29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1172\/JCI200420641","article-title":"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome","volume":"114","author":"Judge","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.acvd.2010.04.008_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.200608167","article-title":"Fibrillin-1 regulates the bioavailability of TGFbeta1","volume":"176","author":"Chaudhry","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.acvd.2010.04.008_bib31","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1074\/jbc.M209256200","article-title":"Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein","volume":"278","author":"Isogai","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.acvd.2010.04.008_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.acvd.2010.04.008_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.acvd.2010.04.008_bib34","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1172\/JCI200422715","article-title":"TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome","volume":"114","author":"Ng","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.acvd.2010.04.008_bib35","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2010.04.008_bib36","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/jama.298.13.1539","article-title":"Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial","volume":"298","author":"Ahimastos","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2010.04.008_bib37","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.amjcard.2005.01.032","article-title":"Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome","volume":"95","author":"Yetman","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2010.04.008_bib38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ahj.2007.06.024","article-title":"Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome","volume":"154","author":"Lacro","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2010.04.008_bib39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2459\/JCM.0b013e3283232a45","article-title":"Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations","volume":"10","author":"Gambarin","year":"2009","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.acvd.2010.04.008_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9149(89)90430-X","article-title":"Two-dimensional echocardiographic aortic root dimensions in normal children and adults","volume":"64","author":"Roman","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2010.04.008_bib41","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.amjcard.2009.11.040","article-title":"Nomograms for aortic root diameters in children using two-dimensional echocardiography","volume":"105","author":"Gautier","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2010.04.008_bib42","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrm2262","article-title":"Extracellular control of TGFbeta signalling in vascular development and disease","volume":"8","author":"ten Dijke","year":"2007","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213610001117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213610001117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:38:07Z","timestamp":1761745087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213610001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1875213610001117"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2010.04.008","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2010.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}